However, there is some evidence to suggest that previous TNF antagonist therapy in patients with rheumatoid arthritis is associated with serious infection,25 and switching from a TNF antagonist to a treatment with an alternative mechanism of action may reduce the risks of infection.32 An explanation for these observations is not readily apparent. This evidence concerns the gene TNF and rheumatoid arthritis.